(Q30342476)

20 June 2017

2 references

23 October 2022

Confronting the avian influenza threat: vaccine development for a potential pandemic. (English)

1 reference

20 June 2017

0 references

1 reference

1 reference

5

Jacqueline M Katz

1 reference

20 June 2017

4

Maria C Zambon

1 reference

20 June 2017

Iain Stephenson

1

1 reference

20 June 2017

Karl G Nicholson

series ordinal

2

1 reference

20 June 2017

John M Wood

series ordinal

3

1 reference

20 June 2017

publication date

1 August 2004

2 references

Lancet Infectious Diseases

20 June 2017

23 October 2022

2 references

20 June 2017

23 October 2022

4

1 reference

20 June 2017

issue

8

1 reference

20 June 2017

page(s)

499-509

1 reference

Human infection with influenza H9N2.

20 June 2017

cites work

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Antigenic drift and efficacy of influenza virus vaccines, 1976--1977

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Intranasal immunization with formalin-inactivated virus vaccine induces a broad spectrum of heterosubtypic immunity against influenza A virus infection in mice.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Recombinant baculovirus influenza A hemagglutinin vaccines are well tolerated and immunogenic in healthy adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Evolution and ecology of influenza A viruses

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Biological heterogeneity, including systemic replication in mice, of H5N1 influenza A virus isolates from humans in Hong Kong

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Pathogenesis of avian influenza A (H5N1) viruses in ferrets

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Characterization of the 1918 "Spanish" influenza virus neuraminidase gene.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Clinical studies of monovalent inactivated whole virus and subunit A/USSR/77 (H1N1) vaccine: serological responses and clinical reactions

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

The surface glycoproteins of H5 influenza viruses isolated from humans, chickens, and wild aquatic birds have distinguishable properties.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Cross-subtype protection in humans during sequential, overlapping, and/or concurrent epidemics caused by H3N2 and H1N1 influenza viruses

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Preparation of a standardized, efficacious agricultural H5N3 vaccine by reverse genetics

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Replication of avian influenza viruses in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Pathogenicity and antigenicity of a new influenza A (H5N1) virus isolated from duck meat

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Pandemic preparedness: lessons learnt from H2N2 and H9N2 candidate vaccines

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Boosting immunity to influenza H5N1 with MF59-adjuvanted H5N3 A/Duck/Singapore/97 vaccine in a primed human population

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Safety and antigenicity of whole virus and subunit influenza A/Hong Kong/1073/99 (H9N2) vaccine in healthy adults: phase I randomised trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Characterization of a human H9N2 influenza virus isolated in Hong Kong

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

https://pubmed.ncbi.nlm.nih.gov/15288823

1 reference

12 December 2020

Lack of evidence for human-to-human transmission of avian influenza A (H9N2) viruses in Hong Kong, China 1999

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Lack of adjuvant effect of A1PO4 on purified influenza virus hemagglutinins in man.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Strategies for inducing protection against avian influenza A virus subtypes with DNA vaccines.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Avian-to-human transmission of H9N2 subtype influenza A viruses: relationship between H9N2 and H5N1 human isolates.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Inhibition of interferon-mediated antiviral responses by influenza A viruses and other negative-strand RNA viruses

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Re-emergence of fatal human influenza A subtype H5N1 disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Avirulent Avian influenza virus as a vaccine strain against a potential human pandemic.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Correlation between Rate of Infection and Preexisting Titer of Serum Antibody as Determined by Single Radial Hemolysis during an Epidemic of Influenza A/Victoria/3/75

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

A randomized, double blind study in young healthy adults comparing cell mediated and humoral immune responses induced by influenza ISCOM? vaccines and conventional vaccines

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Avian influenza virus isolated from a woman with conjunctivitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Avian influenza A (H5N1) in 10 patients in Vietnam

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Characterization of H9 subtype influenza viruses from the ducks of southern China: a candidate for the next influenza pandemic in humans?

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Trials of Influenza A/New Jersey/76 Virus Vaccine in Normal Children: An Overview of Age-Related Antigenicity and Reactogenicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Origin and evolution of the 1918 "Spanish" influenza virus hemagglutinin gene

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Characterization of the surface proteins of influenza A (H5N1) viruses isolated from humans in 1997-1998.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Influenza DNA vaccines

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Lethal H5N1 influenza viruses escape host anti-viral cytokine responses

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Enhancement of the infectivity of influenza A and B viruses by proteolytic cleavage of the hemagglutinin polypeptide

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Seroepidemiological evidence of avian H4, H5, and H9 influenza A virus transmission to pigs in southeastern China

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Development of a Vero cell-derived influenza whole virus vaccine.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Molecular characterization of H9N2 influenza viruses: were they the donors of the "internal" genes of H5N1 viruses in Hong Kong?

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Receptor specificity of influenza A viruses correlates with the agglutination of erythrocytes from different animal species

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

H5N1 influenza viruses isolated from geese in Southeastern China: evidence for genetic reassortment and interspecies transmission to ducks.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Antibody Responses and Reactogenicity of Graded Doses of Inactivated Influenza A/New Jersey/76 Whole-Virus Vaccine in Humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

An influenza epicentre?

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

A novel mechanism for the acquisition of virulence by a human influenza A virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Early alterations of the receptor-binding properties of H1, H2, and H3 avian influenza virus hemagglutinins after their introduction into mammals

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

An Update on Avian Influenza in Hong Kong 2002

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Determinants of immunity to influenza infection in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Proteolytic cleavage of influenza virus hemagglutinins: primary structure of the connecting peptide between HA1 and HA2 determines proteolytic cleavability and pathogenicity of Avian influenza viruses

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Impact of glycosylation on the immunogenicity of a DNA-based influenza H5 HA vaccine

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

ISCOM vaccine induced protection against a lethal challenge with a human H5N1 influenza virus.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Generation and evaluation of a high-growth reassortant H9N2 influenza A virus as a pandemic vaccine candidate.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Molecular correlates of influenza A H5N1 virus pathogenesis in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Responses of volunteers to inactivated influenza virus vaccines

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Immunity to influenza A H9N2 viruses induced by infection and vaccination

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Evaluation of a recombinant hemagglutinin expressed in insect cells as an influenza vaccine in young and elderly adults.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Genotypic stability of cold-adapted influenza virus vaccine in an efficacy clinical trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Detection of anti-H5 responses in human sera by HI using horse erythrocytes following MF59-adjuvanted influenza A/Duck/Singapore/97 vaccine

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Sialic acid receptor specificity on erythrocytes affects detection of antibody to avian influenza haemagglutinin.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Serological evidence of human infections with avian influenza viruses. Brief report

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Baculovirus-derived hemagglutinin vaccines protect against lethal influenza infections by avian H5 and H7 subtypes

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Summary of Clinical Trials of Influenza Virus Vaccines in Adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Transmission of Eurasian avian H2 influenza virus to shorebirds in North America.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Molecular evolution of H6 influenza viruses from poultry in Southeastern China: prevalence of H6N1 influenza viruses possessing seven A/Hong Kong/156/97 (H5N1)-like genes in poultry

1 reference

https://pubmed.ncbi.nlm.nih.gov/15288823

12 December 2020

Influenza: vaccination and treatment.

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901105-3

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1016/S1473-3099(04)01105-3

1 reference

20 June 2017

0 references

1 reference